19 recommendations regarding the overall evaluation of safety for the development of drugs and 20 biologics2 indicated for improvement of glycemic control in patients with type 2 diabetes 21 mellitus.
The evaluation of new antidiabetic drugs in clinical trials is a multifaceted process that demands rigorous scientific research. From preclinical studies to post-marketing surveillance, each stage serves as a …
Aim: To evaluate Oral Antidiabetic Drugs (OADs) in terms of treatment outcome as well as adherence. Materials and Methods: This was a single-centre cohort study, patients of uncontrolled T2DM on …
The findings highlight how this relatively new family of antidiabetic medications is being used more often in clinical settings. Potential advantages of DPP-4 inhibitors include a favourable adverse-effect …
Department of Quality Assurance Techniques Mr. Thete Ajinkya Dilip Department of Instrumentation and Control Abstract: The antidiabetic properties of synthetic or natural substances can be evaluated by …
Antidiabetic evaluation The synthesized compounds were biologically evaluated for their in vitro -amylase and -glucosidase inhibitory α α potentials using acarbose as a standard drug, and the …
May 25, 2023 · Diabetes Mellitus: Efficacy Endpoints for Clinical Trials Investigating Antidiabetic Drugs and Biological Products Guidance for Industry1 7 6 This draft guidance, when finalized, will represent ...